Literature DB >> 15016855

Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infection.

Petra Mooij1, Ivonne G Nieuwenhuis, Christiaan J Knoop, Robert W Doms, Willy M J M Bogers, Peter J F Ten Haaft, Henk Niphuis, Wim Koornstra, Kurt Bieler, Josef Köstler, Brør Morein, Aurelio Cafaro, Barbara Ensoli, Ralf Wagner, Jonathan L Heeney.   

Abstract

Evidence is accumulating that CD4(+) T-helper (Th) responses play a critical role in facilitating effector responses which are capable of controlling and even preventing human immunodeficiency virus (HIV) infection. The present work was undertaken to determine whether immunization with multiple antigens influenced individual Th responses and increased protection relative to a single antigen. Rhesus macaques were primed with DNA and boosted (immune-stimulating complex-formulated protein) with a combination of regulatory and structural antigens (Tat-Env-Gag) or with Tat alone. Immunization with combined antigens reduced the magnitude of the responses to Tat compared to the single-antigen immunization. Interestingly, the Th immune responses to the individual antigens were noticeably different. To determine whether the qualitative differences in vaccine-induced Th responses correlated with vaccine efficacy, animals were challenged intravenously with simian/human immunodeficiency virus (strain SHIV(89.6p)) 2 months following the final immunization. Animals that developed combined Th1- and Th2-like responses to Gag and Th2 dominant Env-specific responses were protected from disease progression. Interestingly, one animal that was completely protected from infection had the strongest IFN-gamma and interleukin-2 (IL-2) responses prior to challenge, in addition to very strong IL-4 responses to Gag and Env. In contrast, animals with only a marked vaccine-induced Tat-specific Th2 response (no IFN-gamma) were not protected from infection or disease. These data support the rationale that effective HIV vaccine-induced immunity requires a combination of potent Th1- and Th2-like responses best directed to multiple antigens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15016855      PMCID: PMC371051          DOI: 10.1128/jvi.78.7.3333-3342.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

Review 1.  The critical role of CD4(+) T-cell help in immunity to HIV.

Authors:  Jonathan Luke Heeney
Journal:  Vaccine       Date:  2002-05-06       Impact factor: 3.641

2.  Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication.

Authors:  Todd M Allen; Lorenzo Mortara; Bianca R Mothé; Max Liebl; Peicheng Jing; Briana Calore; Marian Piekarczyk; Richard Ruddersdorf; David H O'Connor; X Wang; Chenxi Wang; David B Allison; John D Altman; Alessandro Sette; Ronald C Desrosiers; Gerd Sutter; David I Watkins
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory.

Authors:  Christine Bourgeois; Benedita Rocha; Corinne Tanchot
Journal:  Science       Date:  2002-09-20       Impact factor: 47.728

4.  Dynamics of T cell responses in HIV infection.

Authors:  Victor Appay; Laura Papagno; Celsa A Spina; Pokrath Hansasuta; Abigail King; Louise Jones; Graham S Ogg; Susan Little; Andrew J McMichael; Douglas D Richman; Sarah L Rowland-Jones
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

5.  An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys.

Authors:  K A Reimann; J T Li; G Voss; C Lekutis; K Tenner-Racz; P Racz; W Lin; D C Montefiori; D E Lee-Parritz; Y Lu; R G Collman; J Sodroski; N L Letvin
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

6.  Outcome of simian-human immunodeficiency virus strain 89.6p challenge following vaccination of rhesus macaques with human immunodeficiency virus Tat protein.

Authors:  Peter Silvera; Max W Richardson; Jack Greenhouse; Jake Yalley-Ogunro; Nigel Shaw; Jyotika Mirchandani; Kamel Khalili; Jean-Francois Zagury; Mark G Lewis; Jay Rappaport
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  Enumeration of lymphokine-secreting cells as a quantitative measure for cellular immune responses in rhesus macaques.

Authors:  P H van der Meide; R J Groenestein; M C de Labie; J Heeney; P Pala; M Slaoui
Journal:  J Med Primatol       Date:  1995-12       Impact factor: 0.667

8.  Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine.

Authors:  Rama Rao Amara; James M Smith; Silvija I Staprans; David C Montefiori; Francois Villinger; John D Altman; Shawn P O'Neil; Natalia L Kozyr; Yan Xu; Linda S Wyatt; Patricia L Earl; James G Herndon; Janet M McNicholl; Harold M McClure; Bernard Moss; Harriet L Robinson
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

9.  Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1.

Authors:  M Girard; B Meignier; F Barré-Sinoussi; M P Kieny; T Matthews; E Muchmore; P L Nara; Q Wei; L Rimsky; K Weinhold
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: consequences of challenge.

Authors:  W M Bogers; H Niphuis; P ten Haaft; J D Laman; W Koornstra; J L Heeney
Journal:  AIDS       Date:  1995-12       Impact factor: 4.177

View more
  14 in total

1.  AIDS vaccination studies with an ex vivo feline immunodeficiency virus model: analysis of the accessory ORF-A protein and DNA as protective immunogens.

Authors:  Mauro Pistello; Francesca Bonci; J Norman Flynn; Paola Mazzetti; Patrizia Isola; Elisa Zabogli; Valentina Camerini; Donatella Matteucci; Giulia Freer; Paolo Pelosi; Mauro Bendinelli
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Intergenic region 3 of modified vaccinia ankara is a functional site for insert gene expression and allows for potent antigen-specific immune responses.

Authors:  Edwin R Manuel; Zhongde Wang; Zhongqi Li; Corinna La Rosa; Wendi Zhou; Don J Diamond
Journal:  Virology       Date:  2010-05-14       Impact factor: 3.616

3.  Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels.

Authors:  Ranajit Pal; David Venzon; Sampa Santra; Vaniambadi S Kalyanaraman; David C Montefiori; Lindsey Hocker; Lauren Hudacik; Nicolas Rose; Janos Nacsa; Yvette Edghill-Smith; Marcin Moniuszko; Zdenek Hel; Igor M Belyakov; Jay A Berzofsky; Robyn Washington Parks; Phillip D Markham; Norman L Letvin; Jim Tartaglia; Genoveffa Franchini
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

4.  Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells.

Authors:  Hong Yu; Xiaozhou Jiang; Caixia Shen; Karuna P Karunakaran; Janina Jiang; Nicole L Rosin; Robert C Brunham
Journal:  Infect Immun       Date:  2010-03-15       Impact factor: 3.441

5.  Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.

Authors:  Xiaoping Liang; Danilo R Casimiro; William A Schleif; Fubao Wang; Mary-Ellen Davies; Zhi-Qiang Zhang; Tong-Ming Fu; Adam C Finnefrock; Larry Handt; Michael P Citron; Gwendolyn Heidecker; Aimin Tang; Minchun Chen; Keith A Wilson; Lori Gabryelski; Michael McElhaugh; Anthony Carella; Cheryl Moyer; Lingyi Huang; Salvatore Vitelli; Deepa Patel; Jing Lin; Emilio A Emini; John W Shiver
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

6.  Identification of a linear peptide recognized by monoclonal antibody 2D7 capable of generating CCR5-specific antibodies with human immunodeficiency virus-neutralizing activity.

Authors:  Surender Khurana; Michael Kennedy; Lisa R King; Hana Golding
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  Robust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model.

Authors:  Gerald K Chege; Wendy A Burgers; Helen Stutz; Ann E Meyers; Rosamund Chapman; Agano Kiravu; Rubina Bunjun; Enid G Shephard; William R Jacobs; Edward P Rybicki; Anna-Lise Williamson
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

8.  HIV-1(89.6) Gag expressed from a replication competent HSV-1 vector elicits persistent cellular immune responses in mice.

Authors:  Scott D Parker; Scott T Rottinghaus; Allan J Zajac; Ling Yue; Eric Hunter; Richard J Whitley; Jacqueline N Parker
Journal:  Vaccine       Date:  2007-07-27       Impact factor: 3.641

9.  Multiparameter flow cytometry monitoring of T cell responses.

Authors:  Holden T Maecker
Journal:  Methods Mol Biol       Date:  2009

10.  Proliferative activity of extracellular HIV-1 Tat protein in human epithelial cells: expression profile of pathogenetically relevant genes.

Authors:  Alessia A Bettaccini; Andreina Baj; Roberto S Accolla; Fulvio Basolo; Antonio Q Toniolo
Journal:  BMC Microbiol       Date:  2005-04-27       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.